Insider

Teva CEO sold 250,000 shares under a plan

Teva Pharmaceutical Industries Ltd. chief executive officer Richard D. Francis sold 250,000 company shares on November 10, 2026. The deal was executed under a Rule 10b5-1 trading plan, a preset selling schedule executives set up in advance.

Verified against 7 archived primary sources · SHA-256 recorded Inspect sources & citations ↓
a long hallway with pictures on the walls
Photo by zhang shuaizhang on Unsplash
250,000
Shares sold by CEO
4.85%
Company stake held
44,710
Shares sold by executive

Key points

  • Beyond the chief executive officer, other executives also reported stock transactions.
  • The company also reported directors and officers received new conditional shares (derivative securities).

Insider activity and ownership changes

Beyond the chief executive officer, other executives also reported stock transactions. Richard Daniell, executive vice president of Europe commercial, exercised 45,003 options and sold an equal number of shares between November 9 and 11. Mark Sabag, executive vice president of international markets commercial, exercised 44,710 options and sold 44,710 shares on November 12.

Phoenix Financial Ltd. released a report stating it held 56,550,148.77 Teva shares as of November 4, 2026, representing a 4.85% stake in the company.

Value of shares sold, by insider

Daniell Richard$1,928,944.4Sabag Mark$1,973,544.11Francis Richard D$10,559,175
Data from the original sources listed alongside.

Other events and appointments

The company also reported directors and officers received new conditional shares (derivative securities). Specifically, director David J. Brailer received 3,326 units, and interim chief legal officer Dov Bergwerk received 9,433 units on November 10, 2026.

What to watch

Shareholders should monitor further ownership change reports from Phoenix Financial Ltd. via the SEC EDGAR system. Such changes in reporting by major institutional investors may signal shifting sentiment among large capital holders regarding the company.

Original sources

  1. 3 filing, November 12, 2026November 12, 2026SHA-256 of our archived copy ac64599ac314…
  2. 4 filing, November 12, 2026November 12, 2026SHA-256 of our archived copy 9604dad52cfb…
  3. 4 filing, November 12, 2026November 12, 2026SHA-256 of our archived copy a95c1b27243d…
  4. 4 filing, November 12, 2026November 12, 2026SHA-256 of our archived copy 9462a434c635…
  5. 4 filing, November 12, 2026November 12, 2026SHA-256 of our archived copy 9768c0b1abd5…
  6. 4 filing, November 12, 2026November 12, 2026SHA-256 of our archived copy be8de5f86fe9…
  7. SCHEDULE 13G/A filing, November 16, 2026November 16, 2026SHA-256 of our archived copy e6d5b16a8d01…
Cite this article

The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.

Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards